Pharmaceutical Fine Chemicals Market Report by Type, Product, Size, Application, and Region 2025-2033
IMARC Group은 2024년 의약품 정밀화학 세계 시장 규모가 1,491억 달러에 달했으며, 2025-2033년 연평균 성장률(CAGR)은 5.38%로 2033년에는 2,447억 달러에 달할 것으로 예측하고 있습니다.
파인케미컬은 고가에 한정된 수량만 생산되는 순수하고 복잡한 화학제품을 말합니다. 이러한 화학제품은 다단계 배치식 생명공학 기법의 지원을 받아 다목적 플랜트에서 생산됩니다. 특수 화학제품과 달리 이러한 물질은 명확한 기능적 특성과 특정 분자 특성에 따라 정확하게 축적됩니다. 회수 후, 정밀화학은 마그네슘 스테아레이트, 젤라틴 등 일부 의약화학제품을 제조하기 위한 주제, 안정제, 용매로 사용됩니다. 현재 이러한 정밀화학제품은 독점적 및 비독점적 변형으로 시판되고 있습니다.
의약품 정밀화학 시장 동향
부정맥, 뇌졸중, 암, 관상동맥 질환 등 다양한 신경 및 심혈관질환의 유병률 증가, 특히 고령층에서 증가하는 것은 의약품 정밀화학 시장을 성장으로 이끄는 주요 요인 중 하나입니다. 이와 함께 코로나 바이러스 감염증(COVID-19) 및 기타 질병에 대한 새로운 백신, 의약품 및 의약품을 도입하기 위해 여러 국가의 정부 기관에서 시행한 유리한 이니셔티브는 의료 부문에서 이러한 의약품의 광범위한 채택을 더욱 촉진하고 있습니다. 이는 시장의 또 다른 성장 촉진요인으로 작용하고 있습니다. 또한, 의약품 제조를 위한 원료로 제약 정밀 화학제품을 사용하기 위한 다양한 지침의 시행은 품질 기준을 충족시키면서 시장 성장에 기여하고 있습니다. 다른 요인으로는 제약 산업의 대폭적인 확장, 연구 개발(R&D) 활동에 대한 투자 증가, 많은 질병과 사용 가능한 약물 옵션에 대한 소비자의 인식이 높아지면서 전 세계적으로 시장 전망을 밝게 하고 있습니다.
본 보고서에서 다루는 주요 질문
- 의약품 정밀화학 세계 시장 규모는?
- 2025-2033년 세계 의약품 정밀화학 시장의 예상 성장률은?
- 세계 의약품 정밀화학 시장을 이끄는 주요 요인은?
- COVID-19가 세계 의약품 정밀화학 시장에 미치는 영향은?
- 의약품 정밀화학 세계 시장에서의 유형별 분류는 어떻게 되는가?
- 의약품 정밀화학 세계 시장에서의 제품별 분류는?
- 의약품 정밀화학 세계 시장 규모에 따른 분류는 어떻게 되는가?
- 의약품 정밀화학 세계 시장에서 주요 지역은 어디인가?
- 세계 의약품 정밀화학 시장의 주요 진출 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 의약품 정밀화학 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 유형별
제7장 시장 내역 : 제품별
제8장 시장 내역 : 사이즈별
제9장 시장 내역 : 용도별
제10장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
- 개요
- 구매자의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 참여업체의 위협
- 대체품의 위협
제14장 가격 분석
제15장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 개요
- BASF SE
- Borregaard ASA
- CHEMADA Industries Ltd.(Turpaz)
- Denisco Chemicals Pvt Ltd
- Dupont De Nemours Inc.
- Eastman Chemical Company
- Evonik Industries AG
- Koninklijke DSM N.V.
- Lonza Group AG
- Solvay S.A.
- Syntor Fine Chemicals Ltd.(Aceto Corporation)
- W. R. Grace and Co.(Standard Industries Inc.)
ksm
The global pharmaceutical fine chemicals market size reached USD 149.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 244.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.38% during 2025-2033.
Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.
Pharmaceutical Fine Chemicals Market Trends:
The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.
Key Market Segmentation:
Breakup by Type:
- Proprietary
- Non-proprietary
Breakup by Product:
- Active Ingredients
- Basic Building Blocks
- Advanced Intermediates
Breakup by Size:
- Big Molecules
- Small Molecules
Breakup by Application:
- Cardiovascular
- Neurological
- Oncological
- Respiratory
- Gastrointestinal
- Musculoskeletal
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).
Key Questions Answered in This Report
- 1.How big is the global pharmaceutical fine chemicals market?
- 2.What is the expected growth rate of the global pharmaceutical fine chemicals market during 2025-2033?
- 3.What are the key factors driving the global pharmaceutical fine chemicals market?
- 4.What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
- 5.What is the breakup of the global pharmaceutical fine chemicals market based on the type?
- 6.What is the breakup of the global pharmaceutical fine chemicals market based on the product?
- 7.What is the breakup of the global pharmaceutical fine chemicals market based on the size?
- 8.What are the key regions in the global pharmaceutical fine chemicals market?
- 9.Who are the key players/companies in the global pharmaceutical fine chemicals market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Pharmaceutical Fine Chemicals Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Proprietary
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Non-proprietary
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Product
- 7.1 Active Ingredients
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Basic Building Blocks
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Advanced Intermediates
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Size
- 8.1 Big Molecules
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Small Molecules
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Application
- 9.1 Cardiovascular
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Neurological
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Oncological
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Respiratory
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Gastrointestinal
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
- 9.6 Musculoskeletal
- 9.6.1 Market Trends
- 9.6.2 Market Forecast
- 9.7 Others
- 9.7.1 Market Trends
- 9.7.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 BASF SE
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Borregaard ASA
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.3 CHEMADA Industries Ltd. (Turpaz)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Denisco Chemicals Pvt Ltd
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Dupont De Nemours Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Eastman Chemical Company
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Evonik Industries AG
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Koninklijke DSM N.V.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Lonza Group AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Solvay S.A.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Syntor Fine Chemicals Ltd. (Aceto Corporation)
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 W. R. Grace and Co. (Standard Industries Inc.)
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 SWOT Analysis
